At the Precision Medicine World Conference, researchers from Sanford Health, Providence Health, and Israel's Maccabi discussed their genomics programs.
The company, which employs 300 people, axed 30 jobs in the US and 25 jobs from its overseas operations as it refocuses on therapeutic development.
In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.
About 77 percent of the species the researchers uncovered in a human microbiome study of more than 9,000 metagenomes had never before been described.
The company also reaffirmed its guidance for the fourth quarter, and continues to expect revenues of $46.5 million to $48.0 million and EPS of $.09 to $.11.
In Science this week: single-cell tools named Breakthrough of the Year winner, differences in gut microbiome composition and function in people with bowel disease, and more.
Hmong and Karen immigrants to the US quickly lost diversity in their microbiomes and experienced shifts in the microbes present in their guts.
Each stage is associated with an increase in gut microbial diversity and is influenced by breastfeeding, researchers reported this week.
New York City Department of Health and Mental Hygiene researchers discovered almost 700 bacterial species in the city's drinking water, including samples before and after treatment.
Stanford University researchers used a new bioinformatic tool they developed to examine relatedness between bloodstream pathogens and the gut microbiome.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.